GERD Drug Approved for Younger Children

Ages 1 to 11

THURSDAY, Feb. 28 (HealthDay News) -- Nexium, a popular drug to treat gastroesophageal reflux disease (GERD) in adults, has been approved for the same short-term use in children ages 1 to 11, the U.S. Food and Drug Administration said Thursday.

Two forms of Nexium (esomeprazole magnesium) were approved for younger children -- a delayed-release capsule and a liquid form. Doses approved for this age group are half of those approved for older children, the agency said. The drug was previously approved for children ages 12 to 17.

Advertisement

Related Stories • Scientists ID Enzyme That Allows Dysentery Amoeba to Hide • Weight Loss After Gastric Bypass Is Key to Easing Diabetes • High-Volume Hospitals Better for Abdominal Aortic Rupture Repairs Related Videos DETECTING ACID REFLUX Relief For Chrohn's Sleepless Stomach -- Relief for Nighttime GERD Related Slides Abdominal Aneurysm Enzymes GERD Related Encyclopedia • Acidophilus • Belching • Diffuse Esophageal Spasm

Nexium is among a class of drugs called proton pump inhibitors, which limit production of stomach acid and help heal erosion of the lining of the esophagus.

Common side effects among younger children who used Nexium were headache, diarrhea, abdominal pain, nausea, gas, constipation, dry mouth, and fatigue. The drug's safety and effectiveness haven't been evaluated in children younger than 1 year old, the FDA said.

Nexium is manufactured by AstraZeneca.

More information

The FDA has more about this drug.

-- Scott Roberts